How much funding has Ceramedix Holding, LLC raised?

Ceramedix Holding, LLC has raised $3.0M in total funding, most recently a Grant round.

When was Ceramedix Holding, LLC founded?

Ceramedix Holding, LLC was founded in 2018.

Where is Ceramedix Holding, LLC headquartered?

Ceramedix Holding, LLC is headquartered in New York, New York, United States.

What industry is Ceramedix Holding, LLC in?

Ceramedix Holding, LLC operates in Biotech, Healthcare.

How many employees does Ceramedix Holding, LLC have?

Ceramedix Holding, LLC has 1-10 employees.

Ceramedix Holding, LLC

Q: Who are Ceramedix Holding, LLC's investors?

Ceramedix Holding, LLC's investors include National Institute of Allergy and Infectious Diseases.

Ceramedix

New York, United States · Founded 2018 · $3.0M raised

Biotech

Healthcare

Headquarters: New York, New York
Employees: 1–10
Founded: 2018
Business Model: B2B

Website: ceramedix.com
Total Funding: $3.0M
Last Round: $3.0M GrantAug 2023
Rounds: 1

About

Ceramedix is a preclinical-stage biotherapeutics company developing a novel class of pharmacologic drugs targeting disease mechanisms involving the microvasculature. The company's lead candidate is an anti-ceramide antibody designed to disrupt cell death signaling, with initial applications in radiation exposure mitigation and ophthalmic diseases including diabetic retinopathy. Ceramedix has received multiple NIH SBIR grants including a Phase 2B award to support IND submission.

Summary

Ceramedix Holding, LLC is a Biotech company based in New York, United States, founded in 2018. It has raised $3.0M in total across 1 round, most recently a $3.0M Grant round in Aug 2023. Investors include National Institute of Allergy and Infectious Diseases.